Issue 56, 2014

Prussian blue nanoparticles for laser-induced photothermal therapy of tumors

Abstract

We describe Prussian blue nanoparticles (PB NPs) for laser-induced photothermal therapy (PTT) of tumors. The PB NPs exhibit strong absorbance at near infrared (NIR) wavelengths, are stable, non-toxic, and have 20.5% photothermal conversion efficiencies. PTT with PB NPs in a mouse model of neuroblastoma resulted in marked tumor debulking, increased tumor-free days, and decreased tumor growth rates in tumor-bearing mice. These findings demonstrate the clinical potential of PB NPs for PTT of tumors.

Graphical abstract: Prussian blue nanoparticles for laser-induced photothermal therapy of tumors

Supplementary files

Article information

Article type
Communication
Submitted
21 Apr 2014
Accepted
26 Jun 2014
First published
26 Jun 2014

RSC Adv., 2014,4, 29729-29734

Prussian blue nanoparticles for laser-induced photothermal therapy of tumors

H. A. Hoffman, L. Chakrabarti, M. F. Dumont, A. D. Sandler and R. Fernandes, RSC Adv., 2014, 4, 29729 DOI: 10.1039/C4RA05209A

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements